The Oncology Institute Stock Volatility
| TOIIW Stock | USD 0.02 0.0001 0.43% |
Oncology Institute is out of control given 3 months investment horizon. The Oncology Institute maintains Sharpe Ratio (i.e., Efficiency) of 0.17, which implies the firm had a 0.17 % return per unit of risk over the last 3 months. We were able to collect and analyze data for twenty-nine different technical indicators, which can help you to evaluate if expected returns of 3.76% are justified by taking the suggested risk. Use Oncology Institute Semi Deviation of 13.76, market risk adjusted performance of 2.03, and Coefficient Of Variation of 800.68 to evaluate company specific risk that cannot be diversified away. Key indicators related to Oncology Institute's volatility include:
90 Days Market Risk | Chance Of Distress | 90 Days Economic Sensitivity |
Oncology Institute Stock volatility depicts how high the prices fluctuate around the mean (or its average) price. In other words, it is a statistical measure of the distribution of Oncology daily returns, and it is calculated using variance and standard deviation. We also use Oncology's beta, its sensitivity to the market, as well as its odds of financial distress to provide a more practical estimation of Oncology Institute volatility.
Oncology |
Since volatility provides investors with entry points to take advantage of stock prices, companies, such as Oncology Institute can benefit from it. Downward market volatility can be a perfect environment for investors who play the long game. Here, they may decide to buy additional stocks of Oncology Institute at lower prices. For example, an investor can purchase Oncology stock that has halved in price over a short period. This will lower your average cost per share, thereby improving your portfolio's performance when the markets normalize. Similarly, when the prices of Oncology Institute's stock rises, investors can sell out and invest the proceeds in other equities with better opportunities. Investing when markets are volatile with better valuations will accord both investors and companies the opportunity to generate better long-term returns.
Moving together with Oncology Stock
Moving against Oncology Stock
| 0.77 | VINC | Vincerx Pharma Earnings Call This Week | PairCorr |
| 0.64 | SSKN | STRATA Skin Sciences Earnings Call This Week | PairCorr |
| 0.55 | ELVN | Enliven Therapeutics | PairCorr |
| 0.48 | HOLX | Hologic | PairCorr |
| 0.4 | CDIOW | Cardio Diagnostics | PairCorr |
Oncology Institute Market Sensitivity And Downside Risk
Oncology Institute's beta coefficient measures the volatility of Oncology stock compared to the systematic risk of the entire market represented by your selected benchmark. In mathematical terms, beta represents the slope of the line through a regression of data points where each of these points represents Oncology stock's returns against your selected market. In other words, Oncology Institute's beta of 1.3 provides an investor with an approximation of how much risk Oncology Institute stock can potentially add to one of your existing portfolios. The Oncology Institute is showing large volatility of returns over the selected time horizon. The Oncology Institute is a penny stock. Although Oncology Institute may be in fact a good investment, many penny stocks are subject to artificial price hype. Make sure you completely understand the upside potential and downside risk of investing in The Oncology Institute. We encourage investors to look for signals such as message board hypes, claims of breakthroughs, email spams, sudden volume upswings, and other similar hype indicators. We also encourage traders to check biographies and work history of company officers before investing in instruments with high volatility. You can indeed make money on Oncology instrument if you perfectly time your entry and exit. However, remember that penny stocks that have been the subject of artificial hype usually unable to maintain their increased share price for more than just a few days. The price of a promoted high volatility instrument will almost always revert back. The only way to increase shareholder value is through legitimate performance backed up by solid fundamentals.
3 Months Beta |Analyze The Oncology Institute Demand TrendCheck current 90 days Oncology Institute correlation with market (Dow Jones Industrial)Oncology Beta |
Oncology standard deviation measures the daily dispersion of prices over your selected time horizon relative to its mean. A typical volatile entity has a high standard deviation, while the deviation of a stable instrument is usually low. As a downside, the standard deviation calculates all uncertainty as risk, even when it is in your favor, such as above-average returns.
Standard Deviation | 21.79 |
It is essential to understand the difference between upside risk (as represented by Oncology Institute's standard deviation) and the downside risk, which can be measured by semi-deviation or downside deviation of Oncology Institute's daily returns or price. Since the actual investment returns on holding a position in oncology stock tend to have a non-normal distribution, there will be different probabilities for losses than for gains. The likelihood of losses is reflected in the downside risk of an investment in Oncology Institute.
The Oncology Institute Stock Volatility Analysis
Volatility refers to the frequency at which Oncology Institute stock price increases or decreases within a specified period. These fluctuations usually indicate the level of risk that's associated with Oncology Institute's price changes. Investors will then calculate the volatility of Oncology Institute's stock to predict their future moves. A stock that has erratic price changes quickly hits new highs, and lows are considered highly volatile. A stock with relatively stable price changes has low volatility. A highly volatile stock is riskier, but the risk cuts both ways. Investing in highly volatile security can either be highly successful, or you may experience significant failure. There are two main types of Oncology Institute's volatility:
Historical Volatility
This type of stock volatility measures Oncology Institute's fluctuations based on previous trends. It's commonly used to predict Oncology Institute's future behavior based on its past. However, it cannot conclusively determine the future direction of the stock.Implied Volatility
This type of volatility provides a positive outlook on future price fluctuations for Oncology Institute's current market price. This means that the stock will return to its initially predicted market price. This type of volatility can be derived from derivative instruments written on Oncology Institute's to be redeemed at a future date.Transformation |
The output start index for this execution was zero with a total number of output elements of sixty-one. The Oncology Institute Average Price is the average of the sum of open, high, low and close daily prices of a bar. It can be used to smooth an indicator that normally takes just the closing price as input.
Oncology Institute Projected Return Density Against Market
Assuming the 90 days horizon the stock has the beta coefficient of 1.297 . This usually implies as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Oncology Institute will likely underperform.Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Oncology Institute or Health Care Equipment & Supplies sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Oncology Institute's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Oncology stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
The Oncology Institute has an alpha of 2.7054, implying that it can generate a 2.71 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). Predicted Return Density |
| Returns |
What Drives an Oncology Institute Price Volatility?
Several factors can influence a stock's market volatility:Industry
Specific events can influence volatility within a particular industry. For instance, a significant weather upheaval in a crucial oil-production site may cause oil prices to increase in the oil sector. The direct result will be the rise in the stock price of oil distribution companies. Similarly, any government regulation in a specific industry could negatively influence stock prices due to increased regulations on compliance that may impact the company's future earnings and growth.Political and Economic environment
When governments make significant decisions regarding trade agreements, policies, and legislation regarding specific industries, they will influence stock prices. Everything from speeches to elections may influence investors, who can directly influence the stock prices in any particular industry. The prevailing economic situation also plays a significant role in stock prices. When the economy is doing well, investors will have a positive reaction and hence, better stock prices and vice versa.The Company's Performance
Sometimes volatility will only affect an individual company. For example, a revolutionary product launch or strong earnings report may attract many investors to purchase the company. This positive attention will raise the company's stock price. In contrast, product recalls and data breaches may negatively influence a company's stock prices.Oncology Institute Stock Risk Measures
Assuming the 90 days horizon the coefficient of variation of Oncology Institute is 579.47. The daily returns are distributed with a variance of 474.59 and standard deviation of 21.79. The mean deviation of The Oncology Institute is currently at 14.74. For similar time horizon, the selected benchmark (Dow Jones Industrial) has volatility of 0.89
α | Alpha over Dow Jones | 2.71 | |
β | Beta against Dow Jones | 1.30 | |
σ | Overall volatility | 21.79 | |
Ir | Information ratio | 0.13 |
Oncology Institute Stock Return Volatility
Oncology Institute historical daily return volatility represents how much of Oncology Institute stock's daily returns swing around its mean - it is a statistical measure of its dispersion of returns. The venture shows 21.7852% volatility of returns over 90 . By contrast, Dow Jones Industrial accepts 0.8377% volatility on return distribution over the 90 days horizon. Performance |
| Timeline |
About Oncology Institute Volatility
Volatility is a rate at which the price of Oncology Institute or any other equity instrument increases or decreases for a given set of returns. It is measured by calculating the standard deviation of the annualized returns over a given period of time and shows the range to which the price of Oncology Institute may increase or decrease. In other words, similar to Oncology's beta indicator, it measures the risk of Oncology Institute and helps estimate the fluctuations that may happen in a short period of time. So if prices of Oncology Institute fluctuate rapidly in a short time span, it is termed to have high volatility, and if it swings slowly in a more extended period, it is understood to have low volatility.
Please read more on our technical analysis page.| Last Reported | Projected for Next Year | ||
| Selling And Marketing Expenses | 37.4 M | 33.3 M | |
| Market Cap | 173 M | 164.4 M |
Oncology Institute's stock volatility refers to the amount of uncertainty or risk involved with the size of changes in its stock's price. It is a statistical measure of the dispersion of returns on Oncology Stock over a specified period of time, often expressed as the standard deviation of daily returns. In other words, it measures how much Oncology Institute's price varies over time.
3 ways to utilize Oncology Institute's volatility to invest better
Higher Oncology Institute's stock volatility means that the price of its stock is changing rapidly and unpredictably, while lower stock volatility indicates that the price of The Oncology Institute stock is relatively stable. Investors and traders use stock volatility as an indicator of risk and potential reward, as stocks with higher volatility can offer the potential for more significant returns but also come with a greater risk of losses. The Oncology Institute stock volatility can provide helpful information for making investment decisions in the following ways:- Measuring Risk: Volatility can be used as a measure of risk, which can help you determine the potential fluctuations in the value of The Oncology Institute investment. A higher volatility means higher risk and potentially larger changes in value.
- Identifying Opportunities: High volatility in Oncology Institute's stock can indicate that there is potential for significant price movements, either up or down, which could present investment opportunities.
- Diversification: Understanding how the volatility of Oncology Institute's stock relates to your other investments can help you create a well-diversified portfolio of assets with varying levels of risk.
Oncology Institute Investment Opportunity
The Oncology Institute has a volatility of 21.79 and is 25.94 times more volatile than Dow Jones Industrial. Compared to the overall equity markets, volatility of historical daily returns of The Oncology Institute is higher than 96 percent of all global equities and portfolios over the last 90 days. You can use The Oncology Institute to protect your portfolios against small market fluctuations. The stock experiences a normal downward trend and little activity. Check odds of Oncology Institute to be traded at $0.0228 in 90 days.Significant diversification
The correlation between The Oncology Institute and DJI is 0.05 (i.e., Significant diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding The Oncology Institute and DJI in the same portfolio, assuming nothing else is changed.
Oncology Institute Additional Risk Indicators
The analysis of Oncology Institute's secondary risk indicators is one of the essential steps in making a buy or sell decision. The process involves identifying the amount of risk involved in Oncology Institute's investment and either accepting that risk or mitigating it. Along with some common measures of Oncology Institute stock's risk such as standard deviation, beta, or value at risk, we also provide a set of secondary indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Risk Adjusted Performance | 0.1203 | |||
| Market Risk Adjusted Performance | 2.03 | |||
| Mean Deviation | 14.14 | |||
| Semi Deviation | 13.76 | |||
| Downside Deviation | 16.88 | |||
| Coefficient Of Variation | 800.68 | |||
| Standard Deviation | 21.04 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential stocks, we recommend comparing similar stocks with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Oncology Institute Suggested Diversification Pairs
Pair trading is one of the very effective strategies used by professional day traders and hedge funds capitalizing on short-time and mid-term market inefficiencies. The approach is based on the fact that the ratio of prices of two correlating shares is long-term stable and oscillates around the average value. If the correlation ratio comes outside the common area, you can speculate with a high success rate that the ratio will return to the mean value and collect a profit.
The effect of pair diversification on risk is to reduce it, but we should note this doesn't apply to all risk types. When we trade pairs against Oncology Institute as a counterpart, there is always some inherent risk that will never be diversified away no matter what. This volatility limits the effect of tactical diversification using pair trading. Oncology Institute's systematic risk is the inherent uncertainty of the entire market, and therefore cannot be mitigated even by pair-trading it against the equity that is not highly correlated to it. On the other hand, Oncology Institute's unsystematic risk describes the types of risk that we can protect against, at least to some degree, by selecting a matching pair that is not perfectly correlated to The Oncology Institute.
Additional Tools for Oncology Stock Analysis
When running Oncology Institute's price analysis, check to measure Oncology Institute's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Oncology Institute is operating at the current time. Most of Oncology Institute's value examination focuses on studying past and present price action to predict the probability of Oncology Institute's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Oncology Institute's price. Additionally, you may evaluate how the addition of Oncology Institute to your portfolios can decrease your overall portfolio volatility.